Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

Historical Holders from Q1 2015 to Q3 2025

Symbol
CLLS on Nasdaq
Type / Class
Equity / Ordinary Shares, nominal value EUR0.05 per share
Shares outstanding
95.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
8.31M
Holdings value
$23.7M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
28
Number of buys
13
Number of sells
-9
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ASTRAZENECA PLC 44% $66.4M 44M AstraZeneca PLC 23 Jan 2025
Bpifrance Participations SA 11.1% -15.4% $33.2M $960K 10.6M +2.98% Caisse des Depots 03 Dec 2025
Long Focus Capital Management, LLC 4.6% $6.97M 4.62M LONG FOCUS CAPITAL MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8.31M $23.7M -$5.59M $2.85 28
2025 Q2 11.8M $17.9M -$2.75M $1.52 24
2025 Q1 13.6M $16.9M -$51.5K $1.24 27
2024 Q4 12.8M $23M -$367K $1.80 29
2024 Q3 9.77M $20.9M -$17.2K $2.14 27
2024 Q2 9.77M $18.3M +$2.41M $1.87 27
2024 Q1 9.85M $26.1M +$90.3K $2.65 31
2023 Q4 9.82M $30.2M -$3.43M $3.08 33
2023 Q3 11.5M $18.1M -$4.87M $1.58 28
2023 Q2 14M $27.6M -$2.31M $1.97 31
2023 Q1 15.2M $29.3M +$12.4M $1.93 29
2022 Q4 8.73M $18.3M -$3.51M $2.10 37
2022 Q3 10.3M $23.6M -$1.47M $2.29 43
2022 Q2 10.8M $30.7M -$4.58M $2.83 39
2022 Q1 12.3M $55.7M -$33.3M $4.54 45
2021 Q4 15.2M $124M -$18M $8.12 55
2021 Q3 15.4M $194M -$11.5M $12.61 65
2021 Q2 16.2M $251M +$15.1M $15.47 71
2021 Q1 15.2M $308M -$24.3M $20.21 78
2020 Q4 16.3M $442M +$62.3M $27.06 83
2020 Q3 14.2M $263M +$6.61M $18.50 70
2020 Q2 13.9M $247M -$7.26M $17.80 77
2020 Q1 14.4M $132M +$10.4M $9.20 60
2019 Q4 13.2M $226M +$2.25M $17.12 56
2019 Q3 13.1M $137M -$8.89M $10.40 60
2019 Q2 13.4M $210M +$8.55M $15.60 66
2019 Q1 12.7M $234M +$24.3M $18.34 61
2018 Q4 11.5M $191M -$7.9M $16.65 62
2018 Q3 11.5M $325M +$5.78M $28.22 78
2018 Q2 11.3M $319M +$115M $28.29 82
2018 Q1 7.05M $222M -$5.96M $31.51 67
2017 Q4 7.31M $213M +$42.5M $29.15 55
2017 Q3 5.87M $167M +$17.7M $28.45 41
2017 Q2 5.26M $136M -$10.9M $25.82 39
2017 Q1 5.7M $137M +$1.86M $24.00 39
2016 Q4 5.67M $96.1M -$23.1M $16.95 36
2016 Q3 6.64M $160M -$773K $24.08 38
2016 Q2 6.93M $184M +$12.6M $26.59 38
2016 Q1 6.47M $178M -$18.3M $27.50 43
2015 Q4 7.05M $219M +$7.78M $31.03 47
2015 Q3 6.88M $181M +$7.21M $26.36 43
2015 Q2 6.6M $238M +$18.4M $36.08 40
2015 Q1 6.12M $212M +$212M $34.59 44